iSpecimen Inc. (ISPC) intrinsic value & 10-year financials
iSpecimen Inc. (ISPC) has a Graham intrinsic value of $82.03 per share. At $0.92 on Oct 17, 2026, the stock trades 99% below that value. Over the last 7 fiscal years revenue shrank 25.1% a year to $1.9M, with an average return on invested capital of 61.7%.
- Graham intrinsic value
- $82.03
- Share price (Oct 17, 2026)
- $0.92
- Price vs Graham value
- 99% below
- Market cap
- $4.2M
- Revenue (FY2025)
- $1.9M
- Revenue growth (7-yr CAGR)
- -25.1%
- ROIC (10-yr avg)
- 61.7%
- Free cash flow (FY2025)
- -$4.2M
ISPC 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $1.9M | -$10.5M | -$2.28 | -$4.2M | -465.4% | 1116.1% |
| FY2024 | $9.3M | -$12.5M | -$17.58 | -$8.3M | -137.0% | -273.8% |
| FY2023 | $9.9M | -$11.1M | -$1.23 | -$5.8M | -112.5% | -179.4% |
| FY2022 | $10.4M | -$10.2M | -$1.16 | -$6.0M | -97.9% | -194.0% |
| FY2021 | $11.1M | -$9.0M | -$1.04 | -$10.7M | -53.2% | -108.2% |
| FY2020 | $8.2M | -$4.7M | -$2.48 | -$288.8K | -29.4% | 9.6% |
| FY2019 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
iSpecimen Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
iSpecimen Inc. has historically struggled to out-earn its cost of capital, averaging just -15.7% ROIC.
iSpecimen Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, iSpecimen Inc. is modeled at -25.1% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $82.03 per share.